Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Other Working Capital Changes (2020 - 2025)

Rapid Micro Biosystems' Other Working Capital Changes history spans 6 years, with the latest figure at -$77000.0 for Q3 2025.

  • For Q3 2025, Other Working Capital Changes fell 114.08% year-over-year to -$77000.0; the TTM value through Sep 2025 reached $367000.0, up 391.27%, while the annual FY2024 figure was $626000.0, 330.15% up from the prior year.
  • Other Working Capital Changes for Q3 2025 was -$77000.0 at Rapid Micro Biosystems, down from $14000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $2.6 million in Q3 2021 and bottomed at -$2.6 million in Q4 2021.
  • The 5-year median for Other Working Capital Changes is -$34000.0 (2022), against an average of -$60899.3.
  • The largest YoY upside for Other Working Capital Changes was 27019.81% in 2023 against a maximum downside of 5444.12% in 2023.
  • A 5-year view of Other Working Capital Changes shows it stood at -$2.6 million in 2021, then soared by 73.78% to -$677000.0 in 2022, then skyrocketed by 81.39% to -$126000.0 in 2023, then skyrocketed by 596.83% to $626000.0 in 2024, then plummeted by 112.3% to -$77000.0 in 2025.
  • Per Business Quant, the three most recent readings for RPID's Other Working Capital Changes are -$77000.0 (Q3 2025), $14000.0 (Q2 2025), and -$196000.0 (Q1 2025).